Multiple institutions are presenting innovative advances in radiation oncology at the 2025 ASTRO Annual Meeting. University of California centers and others will showcase developments including targeted radioactive therapies for recurrent prostate cancer, stereotactic body radiation therapy equaling surgery efficacy in early-stage lung cancer, and research from Sylvester Comprehensive Cancer Center. These findings emphasize progress in precision treatments and improved patient outcomes in oncology.